Cystic Fibrosis (CF)
65
31
33
15
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
4.6%
3 terminated out of 65 trials
83.3%
-3.2% vs benchmark
3%
2 trials in Phase 3/4
47%
7 of 15 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 15 completed trials
Clinical Trials (65)
Proof of Principle Study for an Efficacy Trial of Linaclotide for Cystic Fibrosis
Proof-of-concept Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of SION-719 When Added to Trikafta
Feasibility and Acceptance of SonoHeal for Airway Clearance and Preliminary Comparison With the Standard of Care
Gastrointestinal Response of Pediatric Cystic Fibrosis Patients on Mediterranean Diet
Kidney Function in People With Cystic Fibrosis in the Era of HEMT
Muscle Fatigue in People With Cystic Fibrosis: Insight From a Mobile App
Group Cognitive Behavioural Therapy for Adults With Cystic Fibrosis
A Study to Evaluate Safety and Explore Efficacy of New Lipase NHS7108 in Adult Participants With Exocrine Pancreatic Insufficiency.
MAGNIFY - Pulmonary Magnetic Resonance Imaging for Cystic Fibrosis
Prevalence of Exercise-induced Ventilatory Limitation and Associated Factors in Patients With Cystic Fibrosis Receiving Elexacaftor-Tezacaftor-Ivacaftor
Exercises' Effect on Muscle Strength, Aerobic Capacity and Respiratory Functions in Cystic Fibrosis
Physical Impairments in Children With Cystic Fibrosis
Understanding Inflammation, InFection and Interventions in Severe Exacerbations of Cystic Fibrosis
Identifying the Causes and Risk Factors of Pulmonary Exacerbations in Cystic Fibrosis
Personalized Mobile Health Platform to Promote Physical Activity in Adolescents and Young Adults With Cystic Fibrosis
MRI Assessment of Lung Airways in Cystic Fibrosis: Evaluate MRI's Ability to Detect Changes in Airway Structure .
Phase 2 Study to Assess the Safety and Efficacy of ANG003
ACT With CF Self-Help Toolkit
Characterisation of a Population of Adults Suffering From Cystic Fibrosis in a Belgian Reference Center
Population Pharmacokinetics of Elexacaftor-tezacaftor-ivacaftor in a Paediatric Population